Svmuureports that crypto trading platform Bullish (NYSE: BLSH) released its Q1 2026 earnings, with adjusted revenue of $92.8 million, below the FactSet analyst consensus of $94.9 million. Adjusted EBITDA was $35.1 million, also missing market expectations of $38 million.
Bullish reported a net loss of $604.9 million for the first quarter, or a loss of $3.85 per share, compared to a net loss of $348.6 million in the same period last year. Revenue related to trading decreased year-over-year, impacted by weaker digital asset prices and lower trading activity.
As of pre-market trading on May 14, Bullish shares fell 7.9% to $38.51. Coinbase and Robinhood also previously reported Q1 results that fell short of expectations, with Robinhood's crypto revenue declining 47% year-over-year to $134 million.
Additionally, Bullish previously announced an agreement to acquire Equiniti, a share registry and shareholder services company, for $4.2 billion to expand its tokenized securities business. (CoinDesk)
Bullish Q1 revenue misses expectations, shares fall nearly 8% pre-market
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
3
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
4
The analysis points out that Iran’s overlapping centers of power complicate efforts to end the war with the United States, and that the Revolutionary Guards possess significant operational autonomy.
-
5
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
6
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
7
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
8
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
9
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
10
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
Markets Today
Recommended Reading








